Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Metin, Kanitez"'
Autor:
Nil, Molinas Mandel, Fatih, Selcukbiricik, Metin, Kanitez, Suayip, Yalcin, Deniz, Tural, Sibel, Erdamar, Gulen, Dogusoy, Gokhan, Demir
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(2)
Gastrointestinal stromal tumors (GISTs) are common tumors of the gastrointestinal tract. Their most frequent location is the stomach. Although the clinical and pathological characteristics of the disease are well-known, the clinical and pathological
Background: Erlotinib is a targeted anti-cancer drug which acts through the inhibition of epidermal growth factor receptor (EGFR). Main observations: A 79-year-old developed bilateral ectropion after he received erlotinib treatment for lung adenocarc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3baf43ff8667a591a934a106356fb4df
https://hdl.handle.net/11424/245985
https://hdl.handle.net/11424/245985
Autor:
Ibrahim, Yildiz, Meltem, Ekenel, Tulay, Akman, Muharrem, Kocar, Mükremin, Uysal, Metin, Kanitez, Umut, Varol, Ibrahim Vedat, Bayoglu, Deniz, Tural, Mehmet Ali, Kaplan, Nilufer, Avci, Zeki, Sürmeli, İsa, Dede, Arife, Ulaş, Ozan, Yazici, Mert, Basaran
Publikováno v:
Anticancer research. 34(8)
This study aimed to assess the clinical efficacy and toxicity of sunitinib, a targeted-agent, for non-clear cell renal cell carcinoma.Sixty-three patients with complete clinical data from 13 oncology Centers were retrospectively evaluated. Outcomes a
Autor:
Metin Kanitez, Gulce Celik, Umit Ugurlu, Faysal Dane, Murat Sunbul, Nazim Serdar Turhal, Fulden Yumuk, Rahib Hasanov, Mehmet Besiroglu, Sina Mokhtare, Reshad Rzayev, Bilge Aktas
Publikováno v:
Journal of Clinical Oncology. 34:e12014-e12014
e12014Background: The prevalence of cardiovascular disease (CVD) is unexpectedly high and suboptimally managed in cancer. Increased epicardial fat thickness (EFT) is associated with subclinical ath...
Autor:
Metin Kanitez, Burak Yasin Aktas, Perran Fulden Yumuk, Nazim Serdar Turhal, Selcuk Seber, Faysal Dane, Kocak M, Ferhat Telli, Butur S
Publikováno v:
Pharmaceutica Analytica Acta.
Introduction: Incidences of cancer in males and females in Turkey are increasing rapidly. However, current incidences are approximately one third of those found in the developed world. In the European Union, Turkey is the sixth largest spender on can
Autor:
Zeki Gokhan Surmeli, Isa Dede, Mert Basaran, Metin Kanitez, Muhammet Ali Kaplan, Nilufer Avci, Meltem Ekenel, Vedat Bayoglu, Tulay Akman, Mukremin Uysal, Umut Varol, Muharrem Kocar, Ozan Yazıcı, Arife Ulas, Deniz Tural, Ibrahim Yildiz
Publikováno v:
Journal of Clinical Oncology. 32:e15602-e15602
e15602 Background: Most of the randomizedstudies that have evaluated the clinical outcome of anti-VEGF treatment in metastatic renal cell carcinoma (RCC) were focused mostly on the clear cell histo...
Autor:
Metin Kanitez, Muharrem Kocar, Perran Fulden Yumuk, Nazim Serdar Turhal, Faysal Dane, Ferhat Telli, Mehmet Akif Ozturk, Bilge Aktas, Mehmet Besiroglu, Beste M. Atasoy
Publikováno v:
Journal of Clinical Oncology. 31:e14660-e14660
e14660 Background: Mucinous adenocarcinoma colorectal cancer (CRC) is defined as presence of more than 50% mucinous component and its prognostic significance is debatable. We analyzed the prognostic importance of positivity of any mucinous component
Autor:
Metin Kanitez, Muharrem Kocar, M. Bes¸irog˘lu, Perran Fulden Yumuk, Serdar Turhal, Beste M. Atasoy, Mehmet Akif Ozturk, Faysal Dane, Bilge Aktas, Ferhat Telli
Publikováno v:
Annals of Oncology. 23:ix186
Background Despite the studies showing the impact of each lymphatic, vascular or perineural invasion on prognosis separately, the exact effect of these parameters in together (triple positive) on prognosis is not known. In this study, we assessed the
Autor:
Gokhan Demir, Metin Kanitez, Bilge Aktas, Kerem Okutur, Faysal Dane, E.S. Seber, Perran Fulden Yumuk, Taner Korkmaz, Serdar Turhal
Publikováno v:
Web of Science
Aim and background Serum thymidine kinase 1 (TK1) is a sensitive marker of tumor cell proliferation. It has been reported as a predictive factor for response rate and disease free survival for hematological and early stage solid organ tumors but its
Autor:
Nazim Serdar Turhal, Mahmut Gumus, Ahmet Bilici, Faysal Dane, Metin Kanitez, G. Basaran, Ozkan Kanat, Fuat Dede, Selcuk Seber, Mustafa Canhoroz, Taner Korkmaz, Fulden Yumuk, T. Toptas, Gokhan Demir, Kerem Okutur
Publikováno v:
Journal of Clinical Oncology. 29:e14668-e14668
e14668 Background: Gastric cancer (GC) is one of the leading causes of cancer mortality worldwide. 18F-FDG PET may have a role in predicting patient prognosis on the basis of the metabolic activity...